Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery
By L. Sjöström. Journal of Internal Medicine, 2013
1,808 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Pharmacy, Surgery
View Paper: https://www.semanticscholar.org/paper/4740f1bb6df2faa5d0cf5e2fe8d4c3e9a582d4a9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Pharmacy
In Surgery
Citations in the corpus
- Guidelines for the Primary Prevention of Stroke (2011, positive): “care, showed significant reductions in diabetes mellitus, MI, and stroke.(278) Thirty-six thousand Swedish subjects followed for >13 years again showed a significant decrease in stroke incidence”
- Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery (2014, background): “Recent long-term studies provide evidence of a substantial reduction of mortality in bariatric surgery patients, as well as decreased risk of developing new health-related co-morbidities, together with decreased health care utilization and drop in direct health care costs [10, 13].”
- Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation. (2016, background): “to explain the reduced cancer incidence observed in individuals who are obese who undergo gastric bypass surgery.(69,70) Medications that stimulate weight loss could, in theory, be beneficial in the treatment of patients with cancer who are overweight and obese.”
- Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding (2018, background): “To date, only two reports of very long-term data after bariatric surgery are available [5, 6].”
- Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease (2020, background): “Similarly, long-term follow-up (>17 years) post-surgery in the Swedish Obesity Study showed a 32% reduction in macrovascular complications in T2DM subjects, with 29% fewer myocardial infarctions and a 29% decrease in stroke incidence (638, 639).”